INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 212 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,850,000 | -23.3% | 44,625 | -11.4% | 0.06% | -27.6% |
| Q2 2020 | $2,412,000 | -23.5% | 50,342 | +0.5% | 0.09% | -48.8% |
| Q1 2020 | $3,155,000 | -49.2% | 50,111 | +0.0% | 0.17% | -40.6% |
| Q4 2019 | $6,208,000 | +80.0% | 50,096 | -3.6% | 0.29% | +50.5% |
| Q3 2019 | $3,449,000 | -10.3% | 51,968 | +7.6% | 0.19% | 0.0% |
| Q2 2019 | $3,844,000 | -34.8% | 48,305 | -8.4% | 0.19% | -40.1% |
| Q1 2019 | $5,899,000 | – | 52,740 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |